Levamisole in the treatment of glioblastoma multiforme.
Twenty-five patients with malignant glioma were randomized to receive radiation therapy only or radiation therapy and oral Levamisole. There were no differences in survival between the two groups and therefore no advantage in the use of Levamisole in glioblastoma could be demonstrated.